What is Equitech-Bio?
Equitech-Bio Inc. operates as a critical infrastructure provider for the diagnostic research and laboratory sectors, specializing in the collection and processing of animal plasma. With a portfolio spanning 16 different species, the company provides essential biological components such as albumins and IgG. By maintaining a focus on high-quality standards and sustainable pricing models, Equitech-Bio has cultivated a reputation for reliability over its three-decade tenure. The firm serves as a vital link for researchers who require consistent, high-purity animal-derived products to facilitate complex diagnostic and experimental workflows.
How much funding has Equitech-Bio raised?
Equitech-Bio has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Equitech-Bio
PPP
Public-Private Partnership
What's next for Equitech-Bio?
Following this late-stage funding round, Equitech-Bio is expected to prioritize the scaling of its processing capabilities and the expansion of its global distribution network. The strategic allocation of these funds will likely focus on enhancing supply chain resilience and optimizing the production of specialized serum products to meet the increasing demand from the diagnostic research community. As the company transitions into this next phase of growth, the focus remains on maintaining the rigorous quality control standards that have defined its market presence while exploring new opportunities for product diversification within the biotechnology landscape.
See full Equitech-Bio company page
